Home
Live Updates
Risk of secondary cancers after CAR-T cell therapy low, according to large study : vimarsana.com
Risk of secondary cancers after CAR-T cell therapy low, according to large study
In April, the FDA warned of risk of secondary cancers in people receiving CAR-T cell therapy. A large study now finds the risk is low and not related to the CAR-T cells.
Related Keywords
Virginia ,
United States ,
Takeshi Sugio ,
Troy Noordenbos ,
David Miklos ,
Mark Hamilton ,
Lymph Co Foundation ,
Lymphoma Society ,
National Institutes Of Health ,
Cancer Genomics Program ,
Stanford Cancer Institute ,
Dk Ludwig Fund For Cancer Research ,
Stanford Health Care ,
Ash Alizadeh ,
Moghadam Family Professor ,
New England Journal ,
Stanford Medicine ,
National Institutes ,
Cancer Research ,
vimarsana.com © 2020. All Rights Reserved.